Maintenance chemotherapy in hormone non-responsive breast cancer, assessment of vascular endothelial growth factor (VEGF), soluble Her2 protein (NRP, HER2-ECD) and vascular cellular adhesion molecule-1 (VCAM-1) in serum samples.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fluorouracil; Methotrexate; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 16 Sep 2016 Biomarkers information updated
- 10 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 12 Oct 2012 Planned End Date (1 Dec 2019) added as reported by ClinicalTrials.gov record.